Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor

BACKGROUND AND AIMS: Refractory pruritus and other complications of cholestasis are indications for liver transplantation (LT) in patients with Alagille syndrome (ALGS). We evaluated predictors of event-free survival and transplant-free survival in patients with ALGS treated with maralixibat (MRX),...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokol, Ronald J., Gonzales, Emmanuel M., Kamath, Binita M., Baker, Alastair, Vig, Pamela, Mogul, Douglas B., Garner, Will, Hansen, Bettina E., Jacquemin, Emmanuel, Thompson, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Immune-Mediated Diseases, DILI, and Biliary Tract Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653287/
https://www.ncbi.nlm.nih.gov/pubmed/37278241
http://dx.doi.org/10.1097/HEP.0000000000000502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653287/
https://www.ncbi.nlm.nih.gov/pubmed/37278241
http://dx.doi.org/10.1097/HEP.0000000000000502

Ejemplares similares